We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+4.36%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$228M
AUM Growth
-$4.71M
(-2%)
Cap. Flow
-$9.77M
Cap. Flow
% of AUM
-4.3%
Top 10 Holdings %
Top 10 Hldgs %
50.06%
Holding
75
New
7
Increased
21
Reduced
24
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$4.64M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$3.81M |
| 3 |
SHPG
Shire pic
SHPG
|
+$3.13M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$2.16M |
| 5 |
MacroGenics
MGNX
|
+$1.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Option Care Health
OPCH
|
+$6.12M |
| 2 |
Orthofix Medical
OFIX
|
+$5.87M |
| 3 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
+$4.76M |
| 4 |
ELGX
Endologix Inc
ELGX
|
+$3.29M |
| 5 |
CPHD
Cepheid Inc
CPHD
|
+$3.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.84% |
| 2 | Energy | 4.42% |
| 3 | Communication Services | 1.49% |
| 4 | Real Estate | 1.27% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alkermes
ALKS
$8.22B
| $3.36M | 1.48% |
60,533
-147
| -0.2% | -$7.86K |
|
|
PETX
27
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.94M | 1.29% |
410,176
-57,567
| -12% | -$465K |
|
|
DOC
28
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2.9M | 1.27% |
152,881
+516
| +0.3% | +$9.78K |
|
29
BioMarin Pharmaceuticals
BMRN
$11.6B
| $2.63M | 1.16% |
31,759
-153
| -0.5% | -$13.2K |
|
|
NSTG
30
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.58M | 1.13% |
115,776
-84
| -0.1% | -$1.8K |
|
31
Ionis Pharmaceuticals
IONS
$8.6B
| $2.37M | 1.04% |
49,458
-1,324
| -3% | -$52.4K |
|
|
32
iShares Biotechnology ETF
IBB
$9.34B
| $2.1M | 0.92% |
+23,691
| New | +$2.16M |
|
|
STRM
33
DELISTED
Streamline Health Solutions
STRM
| $2.03M | 0.89% |
108,398
-8,955
| -8% | -$224K |
|
|
TEAR
34
DELISTED
TearLab Corporation
TEAR
| $1.75M | 0.77% |
336,069
-25,356
| -7% | -$144K |
|
35
Vertex Pharmaceuticals
VRTX
$121B
| $1.71M | 0.75% |
23,225
-85
| -0.4% | -$6.92K |
|
|
SRGA
36
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.65M | 0.72% |
16,873
-3,089
| -15% | -$283K |
|
37
QuidelOrtho
QDEL
$1.14B
| $1.61M | 0.71% |
75,280
-6,420
| -8% | -$138K |
|
|
CELG
38
DELISTED
Celgene Corp
CELG
| $1.6M | 0.7% |
13,797
+9,517
| +222% | +$1.06M |
|
|
39
MacroGenics
MGNX
$235M
| $1.26M | 0.56% |
+61,835
| New | +$1.56M |
|
|
XLVS
40
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
| $1.26M | 0.56% |
+17,285
| New | +$1.26M |
|
41
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $1.26M | 0.55% |
+18,241
| New | +$1.27M |
|
42
iShares US Medical Devices ETF
IHI
$3.13B
| $1.01M | 0.44% |
+45,480
| New | +$1.03M |
|
43
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| $712K | 0.31% |
12,036
+4,446
| +59% | +$274K |
|
|
CEMI
44
DELISTED
Chembio diagnostics, Inc.
CEMI
| $519K | 0.23% |
76,302
-1,721
| -2% | -$11.9K |
|
45
iRadimed
IRMD
$1.16B
| $437K | 0.19% |
+39,355
| New | +$424K |
|
|
STJ
46
DELISTED
St Jude Medical
STJ
| $314K | 0.14% |
3,911
| – | – |
|
47
Pfizer
PFE
$143B
| $278K | 0.12% |
9,020
-2,068
| -19% | -$63.1K |
|
48
Sanofi
SNY
$103B
| $272K | 0.12% |
6,720
+1,040
| +18% | +$41K |
|
|
AGRX
49
DELISTED
Agile Therapeutics
AGRX
| $264K | 0.12% |
23
+4
| +21% | +$56K |
|
50
AbbVie
ABBV
$443B
| $260K | 0.11% |
+4,159
| New | +$254K |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2016 Portfolio in Review
As of Q4 2016, First Light Asset Management held 75 positions worth $228M, down 2% from $232M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
First Light Asset Management withdrew a net $9.77M in Q4 2016, closing 22 positions and reducing 24 holdings. Its most notable exit was Option Care Health, an estimated $6.12M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 78% a quarter earlier, followed by Energy and Communication Services.
Against the trend, First Light Asset Management opened a new position in iShares Biotechnology ETF worth $2.1M.
- First Light Asset Management's largest Q4 2016 buy was iShares Biotechnology ETF: 23,691 shares worth $2.1M.
- First Light Asset Management added most to NeoGenomics in Q4 2016, an estimated $4.64M increase.
- First Light Asset Management's biggest Q4 2016 reduction was LeMaitre Vascular, cutting an estimated $504K.
- First Light Asset Management fully exited Option Care Health in Q4 2016, selling an estimated $6.12M.
- First Light Asset Management's ten largest holdings make up 50% of its $228M portfolio in Q4 2016.
- First Light Asset Management opened 7 new positions and closed 22 in Q4 2016.
- First Light Asset Management's portfolio value fell 2% quarter-over-quarter to $228M.
Based on First Light Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.